Literature DB >> 7933702

Color Doppler imaging of orbital venous flow in dysthyroid optic neuropathy.

Y Nakase1, T Osanai, K Yoshikawa, Y Inoue.   

Abstract

Color Doppler imaging was performed to evaluate the venous stasis in 39 orbits, including 9 optic neuropathy orbits, of 20 patients with dysthyroid ophthalmopathy and 22 orbits of 11 healthy subjects. The superior ophthalmic vein (SOV) was detected in 26 dysthyroid ophthalmopathy orbits and in 13 control orbits. The blood flow in the SOV was in the anteroposterior direction in 20 dysthyroid ophthalmopathy orbits and in 13 control orbits. Reversed flow, ie, the flow in the posteroanterior direction, was seen in 6 dysthyroid ophthalmopathy orbits and in none of the control orbits. In dysthyroid ophthalmopathy orbits, the blood flow in the SOV was reversed in 5 (36%) of the 14 orbits with apical orbital crowding observed on computed tomography, which means there was compression of the optic nerve by enlarged extraocular muscles, as compared to in 1 (4%) of the 25 orbits without apical orbital crowding (P < 0.05). The percentage of the orbits having reversed flow in SOV was 44% of dysthyroid ophthalmopathy orbits with optic neuropathy as opposed to 7% of those without optic neuropathy (P < 0.05). Reversed blood flow in the SOV strongly supported the existence of severe venous stasis in the orbits, which may be related to the development of dysthyroid optic neuropathy.

Entities:  

Mesh:

Year:  1994        PMID: 7933702

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  19 in total

1.  Ocular ischaemic syndrome in thyroid eye disease, confirmed using magnetic resonance angiography.

Authors:  A J Shortt; T Fulcher; D Conroy
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

2.  Update on advanced imaging options for thyroid-associated orbitopathy.

Authors:  Michael P Rabinowitz; Jacqueline R Carrasco
Journal:  Saudi J Ophthalmol       Date:  2012-10

3.  Reply to: 'Comment on: Effect of smoking on retrobulbar blood flow in thyroid eye disease'.

Authors:  A Sadeghi-Tari; M Jamshidian-Tehrani; A Nabavi; S Sharif-Kashani; E Elami; N Hassanpour; K A Zamani
Journal:  Eye (Lond)       Date:  2016-12-23       Impact factor: 3.775

4.  Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) using SD-OCT and Angio-OCT.

Authors:  Chiara Del Noce; Aldo Vagge; Massimo Nicolò; Carlo Enrico Traverso
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-02-06       Impact factor: 3.117

5.  Choroidal changes observed with enhanced depth imaging optical coherence tomography in patients with mild Graves orbitopathy.

Authors:  B Özkan; Ç A Koçer; Ö Altintaş; L Karabaş; A Z Acar; N Yüksel
Journal:  Eye (Lond)       Date:  2016-06-17       Impact factor: 3.775

6.  Orbital decompression surgery and horse chestnut seed extract improved superior orbital vein blood flow in patients with thyroid-associated ophthalmopathy.

Authors:  Yu-Jie Wu; Xin Wei; Man-Yi Xiao; Wei Xiong
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

7.  Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation.

Authors:  M N Alp; A Ozgen; I Can; P Cakar; I Gunalp
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

8.  Color Doppler imaging of the superior ophthalmic vein in different clinical forms of Graves' orbitopathy.

Authors:  Mário L R Monteiro; Hélio Angotti-Neto; Joseph E Benabou; Alberto J Betinjane
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

9.  Effect of smoking on retrobulbar blood flow in thyroid eye disease.

Authors:  A Sadeghi-Tari; M Jamshidian-Tehrani; A Nabavi; S Sharif-Kashani; E Elhami; N Hassanpour; K Ameli Zamani
Journal:  Eye (Lond)       Date:  2016-08-19       Impact factor: 3.775

Review 10.  Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy.

Authors:  Allan C Pieroni Gonçalves; Eloísa M M S Gebrim; Mário L R Monteiro
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.